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Abstract: Aflatoxin B1 (AFB1) is commonly found in cereals and animal feeds and causes 
a significant threat to the food industry and animal production. Several microbial isolates 
with high AFB1 transformation ability have been identified in our previous studies. The 
aim of this research was to characterize one of those isolates, Myxococcus fulvus 
ANSM068,  and to explore its biotransformation mechanism. The bacterial isolate of   
M. fulvus ANSM068, isolated from deer feces, was able to transform AFB1 by 80.7% in 
liquid VY/2 medium after incubation at 30 °C for 72 h. The supernatant of the bacterial 
culture was more effective in transforming AFB1 as compared to the cells alone and the 
cell extract. The transformation activity was significantly reduced and eradicated after the 
culture supernatant was treated with proteinase K, proteinase K plus SDS and heating. 
Culture conditions, including nitrogen source, initial pH and incubation temperature were 
evaluated for an optimal AFB1 transformation. Liquid chromatography mass spectrometry 
(LCMS) analyses showed that AFB1 was transformed to a structurally different compound. 
Infrared analysis (IR) indicated that the lactone ring on the AFB1 molecule was modified 
by the culture supernatant. Chromatographies on DEAE-Ion exchange and   
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Sephadex-Molecular sieve and SDS-PAGE electrophoresis were used to determine active 
components from the culture supernatant, indicating that enzyme(s) were responsible for 
the AFB1 biotransformation. This is the first report on AFB1 transformation by a strain of 
myxobacteria through enzymatic reaction(s).  
Keywords:  aflatoxin B1; biotransformation; culture supernatant; Myxococcus fulvus 
ANSM068 
 
1. Introduction  
Aflatoxins are a group of structurally related secondary metabolites produced mainly by Aspergillus 
flavus and Aspergillus parasiticus [1]. Aflatoxin B1 (AFB1), one of the most hazardous mycotoxins, is 
extremely toxic, mutagenic and carcinogenic [2,3]. It poses a severe threat to both livestock 
productivity and human health, thus resulting in huge economic losses worldwide each year [4,5]. 
Interest in biological detoxification of AFB1 has greatly increased during the past decade. Several 
fungal species have been found to be able to biotransform AFB1 into less toxic metabolites; such fungi 
include Pleurotus ostreatus [6], Trametes versicolor [7], Rhizopus sp., Mucor sp. [8], and a few yeasts 
such as Trichosporon mycotoxinivorans [9], Saccharomyces cerevisiae [10], Trichoderma strains [11], 
and  Armillariella tabescens [12]. The biotransformation activities of these fungi were mainly 
demonstrated with cell extracts. However, practical applications of these fungi may be limited by 
factors such as long incubation time required for the detoxification and complicated procedures needed 
for obtaining the active extracts. Reduction of AFB1 by bacteria has also been reported; most of the 
published studies focused on lactic acid bacteria, such as strains belonging to Lactobacillus [13,14], 
Bifidobacterium [15,16], Propionibacterium [17] and Lactococcus [18]. However, the AFB1 reduction 
by these bacteria was proven to be mainly by cell binding rather than biotransformation. Most 
importantly, this kind of binding seems to be reversible, which means that AFB1 can hardly be 
removed completely from contaminated media.  
Recently, several studies reported biological transformation of AFB1 by microbial culture or their 
secondary metabolites. These microbes include Rhodococcus erythropolis [19], Mycobacterium 
fluoranthenivorans [20,21], Stenotrophomonas maltophilia [22] and Nocardia corynebacterioides 
(formerly Flavobacterium aurantiacum) [23–26]. Some studies further explored the role of enzymes in 
secondary metabolites on AFB1 biotransformation [6,27]. Evidence showed that AFB1 
biotransformation by microorganisms and their metabolites, especially enzymes, is specific, effective 
and environmentally sound. 
Myxobacteria are a kind of higher prokaryotic organism and are reported to be a rich source of 
secondary metabolites [28,29]. To date, more than 80 basic structures and 450 structural variants have 
been described from microbes, most of which are exclusively produced by myxobacteria [30]. One of 
the unique characteristics that myxobacteria possess is the prolific production of extracellular lytic 
enzymes and antibiotics, many of which are being used as human drugs [31–36]. It has been well 
studied that all myxobacteria specialize in biotransformation of biomacromolecules [30]. However, 
such microorganisms and their secondary metabolites have not been reported to show mycotoxin Int. J. Mol. Sci. 2010, 11                 
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biotransformation ability. In our previous studies, several microbes with AFB1  biotransformation 
ability were isolated by using a newly developed coumarin medium method [22]. One of those 
microbes that was isolated from deer feces exhibited high AFB1 biotransformation ability in liquid 
culture. It was further identified as a bacterial strain of Myxococcus fulvus and designated M. fulvus K2 
It was later renamed as M. fulvus ANSM068 according to the laboratory’s regulations.  
The objective of this study was to further characterize M. fulvus ANSM068 as an AFB1 
biotransformation agent, to optimize the biotransformation conditions and to explore the 
biotransformation mechanism. 
2. Results and Discussion  
2.1. AFB1 Biotransformation by M. fulvus ANSM068 
The bacterial culture of M. fulvus ANSM068 reduced AFB1 by 80.7% after co-incubation at 30
 °C 
for 72 h. The culture supernatant of M. fulvus ANSM068  was able to reduce AFB1 by 76.6%. 
However, no significant reduction was observed in the treatments with the cells and cell extracts 
(Figure 1). Culture supernatant treated with proteinase K (Prok) displayed significantly decreased 
reduction ability, from 76.6 to 18.9%. No reduction of AFB1 concentration was observed when the 
culture supernatant was treated with Prok plus SDS or with heating (boiling water bath for   
10 min) (Figure 1). 
Figure 1. AFB1 biotransformation by M. fulvus ANSM068. 1. Liquid culture; 2. Culture 
supernatant; 3. Cell extracts; 4. Cell; 5. Proteinase K (Prok) treated culture supernatant;  
6. Prok + SDS treated culture supernatant; 7. Heat treated culture supernatant. The 
reactions were performed at 30 
oC for 72 h. Each value is a mean ± SE of three replicates. 
Means within a row with no common letters differ (P < 0.05).  
 
Myxobacteria became well-known as prolific producers of secondary metabolites during the past 
few decades [37,38]. Thus far, no pathogenic myxobacteria have been observed and many bioactive 
components and drugs were isolated from myxobacteria [39–41]. Myxococcus fulvus was first 
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documented and characterized in 1969 [42]. It is a species of myxobacteria, a group of Gram-negative 
eubacteria with rod-shaped cells. The colonial and cell morphology of M. fulvus ANSM068 are shown 
in Figure 2. It was previously found to be capable of reducing AFB1 [22]. Up to now, no study has 
focused on mycotoxin control by using myxobacteria. This is the first report on mycotoxin 
biotransformation by a bacterial strain belonging to myxobacteria.  
Figure 2. Colony (left) and cell (right) morphology of Myxococcus fulvus ANSM068. 
 
Reduction of AFB1 by culture supernatant produced without pre-exposure to AFB1 suggested that it 
was achieved during the normal growth of the bacterium, indicating that the reduction was a 
constitutive activity of M. fulvus ANSM068. Results from proteinase K, proteinase K plus SDS and 
heating treatments implied that the reduction of AFB1 was due to biotransformation instead of cell 
binding. Protein or enzymes in culture supernatant might be involved in AFB1 biotransformation by 
the bacterial strain. 
2.2. Optimal Culture Conditions for AFB1 Biotransformation 
Nitrogen sources have a dramatic effect on AFB1 biotransformation by M. fulvus ANSM068. Yeast 
extract was found to be the best nitrogen source for AFB1 biotransformation and resulted in 76.6% 
AFB1  biotransformation (Figure 3). In comparison, AFB1  biotransformation was significantly   
(P < 0.05) lower with ammonium nitrate (25.8%). Among the four levels of yeast extract tested (0.2, 
0.5, 0.8 and 1.2%), 0.5% was optimal for AFB1 biotransformation (76.6%). Nitrogen in substrates is 
one of the most important factors influencing myxobacteria growth and production of metabolites. 
Chun [43] studied the effect of different nitrogen sources on the production of antifungal metabolites 
by myxobacteria in liquid culture and found that yeast extract improved secretion of antifungal 
metabolites but fish meal, soybean powder and inorganic nitrogen treatments showed no function. A 
similar trend was also observed in this study.  Yeast extract was most favored in AFB1 
biotransformation by M. fulvus ANSM068 and inorganic nitrogen was far less effective. The reasons 
could be that in natural environments these myxobacteria feed on other organisms such as eubacteria 
or yeasts by bacteriolysis or cellular lysis [44]. The nutrients ratio such as amino acid and vitamins in 
yeast extract might be more suitable to the bacterial strain for its growth and production of AFB1 
biotransformation components. 
Colony on VY/2 plate  Cell (×1000) Int. J. Mol. Sci. 2010, 11                 
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Figure 3. AFB1 biotransformation by M. fulvus ANSM068 in different nitrogen sources.  
1. Yeast extract; 2. Peptone; 3. Beef extract; 4. Tryptone; 5. Fish peptone; 6. Ammonium 
nitrate. The reactions were performed at 30 °C for 72 h. Each value is a mean ± SE of three 
replicates. Means with no common letters differ (P < 0.05).  
 
Figure 4. Effect of initial pH of the medium on AFB1 biotransformation by M. fulvus 
ANSM068. Initial pH value was determined by adjusting the culture pH to 5.0, 5.5, 6.0, 6.5 
by using citrate acid buffer, and to 7.0, 7.5, 8.0, 9.0 by sodium phosphate buffer. The 
reactions were performed at 30 
oC for 72 h. Each value is a mean ± SE of three replicates. 
Means within a row with no common letters differ (P < 0.05). 
 
The initial pH value in culture medium showed a significant effect on AFB1 biotransformation  
(Figure 4). The highest AFB1 biotransformation rate was detected at pH values of 6.5 to 7.5 (P < 0.05). 
It has been well documented that the optimum pH range for myxobacteria is 6.8–7.8 in liquid culture 
[45]. Ahn et al. [46] studied the effect of pH value on antifungal metabolites produced by a 
Myxococcus isolate and found that a pH value between 6.5 and 7.6 was favored and the optimal pH 
value was 7.2.  
The effect of temperature on AFB1 biotransformation by M. fulvus ANSM068 is shown in Figure 5. 
The % biotransformation exhibited was significantly lower (P < 0.05) at 15 °C (11.0%) and 40 °C 
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(18.9%) than at 30
 °C (76.6%). Since the bacterial strain originated from deer feces, a temperature at 
30 °C should be more suitable for the survival and growth of the bacterium, thus optimal for its 
enzyme system. 
Figure 5. Effect of temperature on AFB1 biotransformation by M. fulvus ANSM068. The 
reactions were performed at 30 °C for 72 h. Each value is a mean ± SE of three replicates. 
Means within a row with no common letters differ (P < 0.05).  
 
2.3. AFB1 Biotransformation Product Analysis 
In the analysis by LCMS, AFB1 standard was identified at m/z = 313 for the protonated cation 
[M + H]
+, m/z = 335 for the sodium adduct of AFB1 [M + Na]
+, and at m/z = 351 for the potassium 
adduct [M + K]
+ (Figure 6A); VY/2 medium supplemented with AFB1 clearly showed the above three 
distinct ions (Figure 6B). However, the distinct AFB1 ion at m/z =351 disappeared while the ions at 
m/z = 313 and m/z = 335 significantly decreased after AFB1  was co-incubated with M. fulvus 
ANSM068 culture supernatant for 72 h (Figure 6C). These results suggest AFB1 level was 
significantly reduced although it was still present.  
Additionally, the HPLC chromatograph (Figure 7) confirmed that AFB1 (peak eluting at 8.27 min) 
was biotransformed to a new product eluting at 3.17 min. The IR spectrum showed that there were 
three major modifications in absorption peaks between the standard AFB1 and the product resulting 
from culture supernatant treatment (Figure 8). The absorption peak at 1728 cm
-1 in AFB1 standard 
disappeared after the treatment, which indicates that the lactone attached to the benzene ring was 
modified. The two peaks in the area between 1658 and 1634 cm
-1 in AFB1 standard changed into one 
peak after treatment. The change at 2930 cm
-1 indicates modification of methyl group.  
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Figure 6. Detection of AFB1 by liquid chromatography mass spectrometry. (A) LC-MS 
spectrum of AFB1 standard at 100 ppb showing the distinct ions: [M + H]
+ at m/z = 313, 
[M + Na]
+ at m/z = 335 and [M + K]
+ at m/z = 351. (B) LC-MS spectrum of VY/2 medium 
supplemented with AFB1 standard at 100 ppb. The three distinct ions can clearly be 
distinguished. (C) LC-MS spectrum of AFB1 after 72 h treatment with M. fulvus culture 
supernatant. The ion at 351 disappeared while the ions at 313 and 335 were significantly 
reduced. 
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Figure 7. Detection of AFB1 biotransformation product by HPLC. (A) AFB1 standard with 
concentration of 100 ppb in liquid VY/2 medium. The peak at 8.27 min represents AFB1. 
(B) AFB1 treatment after 72 h incubation with culture supernatant. Peak at 3.17 min 
represents AFB1 biotransformation product. 
 
Alberts et al. [19] explored the AFB1 biotransformation product with Rhodococcus erythropolis 
extracellular fractions by electro spray mass spectrometry and liquid chromatography mass 
spectrometry analysis. By comparing the three distinct AFB1 peaks among treatments, AFB1 was still 
present but at a lower concentration. No breakdown products were revealed, which suggested that 
AFB1 was most likely metabolized to biotransformation products with chemical properties different 
from that of AFB1. Liu et al. [12] compared the infrared spectrum between AFB1 standard and fungal 
enzyme treated AFB1. Opening of the difuran ring was proposed since the group of five bands in the 
area between 1000 cm
-1 and 1200 cm
-1 did not appear in the spectrum of the enzyme treated AFB1. 
Marisa and Das [4] analyzed the biotransformed AFB1 structure by fluorescence spectra measurements 
and TLC. Treatment of AFB1 with purified enzyme resulted in a decrease in fluorescence intensity, 
suggesting the enzymatic cleavage of the lactone ring. The lactone ring was confirmed to be 
responsible for toxicity and mutagenicity in AFB1 [47,48]. In the current study, results from LCMS, 
HPLC and IR analysis confirmed AFB1 biotransformation by M. fulvus ANSM068 instead of cell 
binding. Modification of the lactone ring on the AFB1 molecule may result in detoxification although 
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further investigation needs to be done. This result implies the potential applications of M. fulvus 
ANSM068 or its metabolites in detoxifying AFB1 in contaminated food or feed.  
Figure 8. Infrared spectrometry spectrum of AFB1. (A) Spectrum of AFB1 standard. The 
initial AFB1 concentration was 100 ppb. (B) Spectrum of AFB1 product after 72 h 
incubation with culture supernatant. AFB1 biotransformation product was extracted by 
adding 2 mL chloroform to the incubation mixture and vortexing for 30 seconds.  
 
2.4. Characterization of Active Components from Culture Supernatant 
Since the culture supernatant of M. fulvus ANSM068 exhibited high AFB1 biotransformation 
activity, it was selected for active components extraction. Precipitates from 80% saturated ammonium 
sulfate showed higher AFB1 biotransformation activity, with 54.1% of AFB1 biotransformed. 
Chromatography was used to purify enzyme from the precipitates. Two peaks were obtained by ion 
exchange chromatography on DEAE A-50 column and UV detection at 280 nm (Figure 9A). The 
second peak, which showed AFB1 biotransformation activity (35.5%), was applied to molecular sieve 
chromatography on a Sephadex G-100 column (Figure 9B). SDS-PAGE showed that the active 
components consist of at least three proteins with a relatively small molecular weight between 20 and  
66 kDa (Figure 9C). 
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Figure 9. Determination of active components from culture supernatant by 
chromatography and SDS-PAGE. (A) Ion exchange chromatography on DEAE A-50 
column. The column was pre-equilibrated with 50 mM sodium phosphate buffer pH 7.5. 
Elution was performed with the same buffer for the first 40 mL and then by a gradient of 
0.5 M NaCl added to the buffer. Fractions of 2 mL were collected in tubes at a flow rate of 
0.4 mL/min. (B) Molecular sieve chromatography on Sephadex G-100 column. The 
column was pre-equilibrated with 50 mM sodium phosphate buffer pH 7.5 containing   
0.2 M NaCl. Proteins were eluted with the same buffer. Fractions of 2 mL were collected 
in tubes at a flow rate of 0.2 mL/min. (C) SDS-PAGE analysis of AFB1 biotransformation 
enzyme after purification by chromatography. Lane 1, Calibration marker proteins 
(Pharmacia LKB), 5 µL/lane; lane 2, peak fractions with AFB1 biotransformation activity 
from Sephadex G-100 chromatography, 20 µL/lane.  
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To date, there are only a few reports on extraction or purification of mycotoxin biotransformation 
active components from microbial metabolites. Liu et al. [27] extracted and purified an intracellular 
enzyme from fungi Armillariella tabescens by ammonium sulfate precipitation, ion exchange 
chromatography and chromatofocusing chromatography. The AFB1 detoxification enzyme was then 
characterized to have a molecular mass of 51.8 kDa by SDS-PAGE and it exhibited a specific activity 
of 7.09 nmol min/mg at pH 6.0 and 28 °C. Motomura et al. [6] purified an aflatoxin biotransformation 
enzyme from the edible mushroom Pleurotus ostreatus by two chromatographies on DEAE-Sepharose 
and Phenyl-Sepharose. The apparent molecular mass of the purified enzyme was estimated to be 
90 kDa by SDS-PAGE. This study has confirmed that the AFB1 biotransformation components exist in 
the culture supernatant and are very likely enzyme(s). Further purification and identification of the 
enzyme(s) are undergoing. 
3. Experimental Section  
3.1. Bacterium, Mycotoxin and Medium 
Myxococcus fulvus ANSM068 was isolated and purified from deer feces collected from the Beijing 
Zoo in July, 2006. It was identified using physiological and biochemical tests and 16S rRNA gene 
sequence analysis by the China General Microbiological Culture Collection Center (CGMCC) and has 
been deposited there as CGMCC #3194. It was preserved at –80 °C before use (China Agriculture 
University, Beijing, China).  
AFB1 was obtained from Sigma Chemical Co. (Bellefonte, USA). The medium used for liquid 
culture, VY/2 medium, contains 5 g yeast extract, 1 g CaCl2, 0.5 g MgSO4, 0.5 mg VB12 in 1 L 
distilled water at room temperature. 
3.2. AFB1 Quantification 
For AFB1 analysis, the HPLC procedure by AOAC [49] was used with slight modifications. The 
reaction mixtures were extracted three times with chloroform. The chloroform extracts were 
evaporated under nitrogen at room temperature, the residue was dissolved in 50% methanol in water 
(1:1, v/v) and analyzed by HPLC. HPLC analysis was performed using a LiChroCART RP-C18 (250-4 
Hypersil ODS (5 μm), Merck) column with a guard column (LiChroCART 4-4 RP-C18 (5 μm), 
Merck). The mobile phase was methanol: water (1:1, v/v) isocratic at a flow rate of 1 mL/min. AFB1 
was derivatized by a photochemical reactor (AURA, USA) and measured by a fluorescence detector. 
The excitation and detection wavelengths were set at 360 and 440 nm, respectively. The percentage of 
AFB1 biotransformation was calculated using the following formula:  
(1 – AFB1 peak area in treatment/AFB1 peak area in control) × 100% 
3.3. Efficacy of AFB1 Biotransformation by M. fulvus ANSM068 
Biotransformation of AFB1 by M. fulvus ANSM068 was carried out in liquid culture. The bacterial 
isolate was cultured in VY/2 medium for 24 h and used to inoculate VY/2 (50 mL) in a 300 mL flask, 
which was incubated at 30
 °C with agitation at 160 rpm for 50 h in a Gyrotary shaker incubator Int. J. Mol. Sci. 2010, 11                 
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without AFB1 (Haerbin Donglian Electronic Equipment Inc., China). AFB1 standard solution (Sigma 
Chemical Co., Bellefonte, USA) was diluted with methanol (Beijing Chemical Inc., Beijing, China) to 
a stock solution of 500 ppb, of which 0.2 mL was added to bacterial cultures of 0.8 mL for a final 
concentration of 100 ppb. The biotransformation tests were conducted in the dark at 30
 °C without 
shaking for 72 h. After incubation, bacterial cells were removed by centrifugation at 9,300 g for   
10 min (TGL-16C centrifuge, Beijing Medical Centrifuge Inc., China). Sterile VY/2 medium was used 
to substitute the bacterial culture in the control. 
Biotransformation of AFB1 by cells, culture supernatant and intracellular cell extracts was 
conducted according to the procedure of Shu et al. [22]. Cells were pelleted using a centrifuge at 
9,300 g, 4 °C for 10 min. The pellets were washed twice with a phosphate buffer (50 mM; pH 7.5) 
before being resuspended in the phosphate buffer (5 mL). Culture supernatant was obtained by 
centrifuging 50 h liquid culture at 9,300 g, 4 °C for 10 min. Intracellular cell extracts were harvested 
by the following procedures. The cell suspension was disintegrated twice (work every other 5 s for  
33 min) by using ultrasonic cell disintegrator on ice. The disintegrated cell suspension was centrifuged 
at 9,300 g for 20 min at 4 °C. The cell extracts were collected by filtering the supernatant aseptically 
using 0.2 μm pore size sterile cellulose pyrogen free filters. The phosphate buffer solution (50 mM;  
pH 7.5) was used to substitute intracellular cell extracts and cells in the controls. The effect of protease 
treatment was determined by exposing the culture supernatant to 1 mg/mL proteinase K (Roche 
Diagnostics, Basel, Switzerland; specific activity ≥ 30 U/mg) for 1 h at 37 °C; 1 mg/mL proteinase K 
plus 1% SDS for 6 h at 37 °C. The effect of heat treatment was determined by dipping the culture 
supernatant into a boiling water bath for 10 min. 0.2 mL of AFB1 stock solution was added to 0.8 mL 
of each reaction liquid for a final concentration of 100 ppb. The biotransformation tests were 
conducted in the dark at 30
 °C without shaking for 72 h. After incubation, bacterial cells were removed 
by centrifugation at 9,300 g for 10 min (TGL-16C centrifuge, Beijing Medical Centrifuge Inc., 
China).The untreated culture supernatant was used as control. 
3.4. Culture Conditions Affecting AFB1 Biotransformation  
Unless specifically indicated, all biotransformation experiments were conducted by using culture 
supernatant at 30 °C for 72 h with aeration. Culture supernatant was obtained by centrifuging 50 h 
culture with 9,300 g at 4 °C for 20 min. 
To detect the appropriate nitrogen source for the bacterial growth with optimum AFB1 
biotransformation, 0.5% of tryptone, peptone, beef extract, yeast extract, fish peptone and ammonium 
nitrate (NH4NO3) were chosen as the nitrogen source in the culture medium.  
Initial pH value in VY/2 medium was adjusted to 5.0, 5.5, 6.0 by using citrate acid buffer, and to 
6.5, 7.0, 7.5, 8.0, 9.0 by sodium phosphate buffer.  
Cultivation was performed at 15, 20, 25, 30, 35 and 40
 °C respectively for 50 h before the culture 
supernatants were harvested.  
3.5. AFB1 Biotransformation Product Analysis 
The biotransformation products of AFB1 after 72 h incubation with culture supernatants were 
determined by liquid chromatography mass spectrometry (LCMS) and infrared analysis (IR).  Int. J. Mol. Sci. 2010, 11                 
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For LCMS, the following samples were analyzed: (a) AFB1 standard, (b) VY/2 medium supplemented 
with AFB1, (c) AFB1 treated with culture supernatants for 72 h. The samples were extracted with 
chloroform, dried under nitrogen, suspended in methanol: water (1:1, v/v) and analyzed by LCMS 
using a Phenomenex 2.0 × 150 mm C18 column and methanol: acetonitrile: water (1:1:2, v/v/v) as 
solvent, at a flow rate of 100 µL/min.The HPLC system was equipped with a Finnigan Spectra System 
UV6000LP ultraviolet (UV) detector. Atmospheric pressure chemical ionization (APCI) positive ion 
mode was used for MS detection (ThermoFinnigan, San Jose, CA, USA). 
For IR analysis, 2 mL chloroform was added to the incubation mixture and vortexed for 30 seconds. 
The phases were separated by low-speed centrifugation and the organic phase was evaporated to 
dryness at 20 
oC under N2. The samples were purified by HPLC before IR analysis. IR analysis was 
carried out with a KBr pellet using an IR spectrophotometer (NEXUS-470F TIR, Nicolet, Japan). 
Sterile VY/2 medium was used to substitute culture supernatant in the control. 
3.6. Determination of Active Components from Culture Supernatant  
3.6.1. Precipitation of Active Components 
Methanol, acetone, ethanol and solid ammonium sulphate were used to precipitate the active 
components. For the organic solvents, 500 mL of each of the chilled solvent was added to 150 mL of 
the culture supernatant. For ammonium sulphate, 150 mL of the culture supernatant was supplemented 
to 20, 40, 60 and 80% saturation respectively under constant stirring. The above solutions were stored 
at 4 
oC for 4 h followed by centrifugation at 9,300 g for 20 min. The precipitates were dissolved in  
2 mL of 50 mM sodium phosphate buffer (pH 7.5). The ammonium sulphate treatments were dialysed 
over night against distilled water before being applied to chromatography. 
3.6.2. Purification of the Active Components by Chromatography  
The dialyzed samples were applied to a DEAE A-50 Ion exchange column (Pharmacia Biotech, 
Sweden) pre-equilibrated with 50 mM sodium phosphate buffer pH 7.5. Elution was performed with 
the same buffer and by a gradient of 0.5 M NaCl in the buffer. Fractions of 2 mL were collected in 
separate tubes at a flow rate of 0.4 mL/min. The protein concentration in each eluted fraction was 
detected at 280 nm using a UV-visible spectrophotometer. The fractions with AFB1 biotransformation 
activity were combined and applied to a Sephadex G-100 Molecular sieve column (Pharmacia)   
pre-equilibrated with 50 mM sodium phosphate buffer containing 0.2 M NaCl. Proteins were eluted 
with the same buffer and fractions of 2 mL were collected in separate tubes at a flow rate of   
0.2 mL/min. After dialysis against buffer, the AFB1 biotransformation activity of each fraction   
was tested. 
3.6.3. Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was performed in 12.5% polyacrylamide gels according to the method of   
Motomura et al. [6]. The separated proteins were stained with Coomassie Brilliant Blue R-250 (Fluka, 
Switzerland) and their molecular weights were determined by comparison with low range molecular 
weight markers (Pharmacia Biotech, Uppsala, Sweden). Int. J. Mol. Sci. 2010, 11                 
 
 
4076
3.7. Statistical Analyses 
The results were average of triplicates and were expressed as mean ± standard error. Data were 
analyzed as a completely randomized single factor design by ANOVA using the general linear models 
procedure in SAS. Significant F tests at the 0.05 levels of probability are reported. When a significant 
F-value was detected, Duncan’s Multiple Range Test was used to determine significant differences 
among means. 
4. Conclusions  
The present study demonstrated the ability of M. fulvus ANSM068 to effectively biotransform 
AFB1. Furthermore, optimal conditions for biotransformation were determined as follows: 0.5% of 
yeast extract as nitrogen source; initial pH value at 7.5; temperature at 30 °C. The results indicated that 
enzyme(s) in the culture supernatant was responsible for the biotransformation although further 
confirmation is needed. Research is underway to purify the effective enzyme(s) and to identify 
metabolites produced during the biotransformation processes. The AFB1 biotransformation enzymes, 
once identified, may be mass-produced by the bacterial isolate and be used to treat materials 
contaminated with AFB1.  
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